Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy - Wikidata - wikimedia - TriplyDB

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

http://www.wikidata.org/entity/Q28343848

about

Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3 Enhancing or eliminating signals for cell survival to treat disease.Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.Novel insights into hydrogen sulfide--mediated cytoprotection.Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPKα/mTOR axis.P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.Hydrogen sulfide and ischemia-reperfusion injury.Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure.Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.Cardiac hypertrophy and failure: lessons learned from genetically engineered mice.Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation.Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotection Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity New frontiers in heart hypertrophy during pregnancy.The varying faces of IL-6: From cardiac protection to cardiac failure.Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics.Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion.Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress.STAT transcription in the ischemic heart.Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death.Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts.Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics.Catecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70 kinase and c-Jun NH(2)-terminal kinase 2.Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death.Hydrogen sulfide mediates cardioprotection through Nrf2 signaling.Maternal dietary restriction during the periconceptional period in normal-weight or obese ewes results in adrenocortical hypertrophy, an up-regulation of the JAK/STAT and down-regulation of the IGF1R signaling pathways in the adrenal of the postnata Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.JAK-STAT signaling and myocardial glucose metabolism.Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy.gp130-mediated pathway and heart failure.STAT3 and cardiac remodeling.

P2860

Q22253414-C1D9A764-C751-474A-BBCB-7BFF37E6A4AA Q26748618-6F5F7583-AD91-4496-BC74-E1C9E474DFB2 Q28396645-AEE3E23B-A104-4EA8-91A9-7D83798E969C Q30498584-2341B82E-3047-4B98-9981-5739858DFD4C Q33632353-345DD8AF-0447-4534-8F59-BD2D1C5D7578 Q33830124-E5703FA3-E57D-478B-A4C7-4DFF77DB21EC Q33863961-6732F818-C318-4671-945F-CE8305BF78C9 Q33883642-7196E8A0-E126-42CC-A68B-8BA00D08C8F4 Q34048273-93D85290-D7BF-4054-B470-0C85E72BD852 Q34049947-443A7C58-A52C-47C7-826D-3F13B20AA51C Q34102834-C0920401-0D7A-47E1-91C5-F66D4DE165C3 Q34116906-204CC288-866F-46A7-A34C-4231B1D93CA5 Q34357753-888CE759-88F5-4716-856D-6D9430242E29 Q34418993-EA4548EB-A333-4ADC-8C6E-56CA28D66A45 Q34550563-DD9DD3C5-E8CD-4A52-955B-ED04127276D6 Q34789646-477AB4CE-A6A2-4747-AC76-9B873023135D Q34805921-4E3A54EA-73FE-453B-ABBC-1B7F6D6248DF Q35313598-2B973D7B-8200-43A3-ADC9-A688845AA871 Q35832107-7D3A6819-E930-4F72-95E5-9E507D9A1E69 Q36190273-A9D825C6-78DA-4926-B354-703539B05D61 Q36368339-3578EE4F-E0E9-4B28-8CD9-8E67B9DF85B0 Q36497007-565B2B41-9247-481A-85D9-81A8AF9AFC12 Q36630478-7EDD6D6A-7527-4F04-A698-C4108ACC9112 Q36637796-1C83AD9F-F27C-422D-B32C-C4223C01EB2D Q36776721-400032AC-678C-4DD4-8C2C-1C5AE38881C1 Q36895459-C0118E96-3B11-47DF-94EF-E38E8DFDE606 Q36895468-9A397A1B-F0DB-428E-BDD7-5909860DB4A6 Q37024066-512393D2-1AD6-4D3D-8C90-D9269C3B4C16 Q37033644-946AB1DC-9DED-4E0F-8C91-1AE931BF7203 Q37184746-FB71230C-7C24-45C2-9A3A-5FC139EBB86D Q37203741-E76701CC-F9EA-49F9-BF5A-B969B4830B75 Q37284655-9ACBA59C-E44A-4577-A3A2-57269E0BA923 Q37292925-0DC99360-1160-49E3-8C98-D0C1404D858D Q37328256-94D09F51-FCE2-4B60-AAD1-F8B0CF8C0AF7 Q37331095-4FFB4C19-4180-484B-952F-23B4D202ACF5 Q37412473-B5216D36-1B33-4C7C-A4FF-D9115754906B Q37421817-C9CDD60F-B184-4ADC-91CB-4CAB1C348E89 Q37467862-F54623CD-5B00-40CA-B81F-96D286DB06D4 Q37608600-FA17B132-822E-4471-ABF6-846AA580A9CB Q37734934-0A60D12F-DEF3-4EBC-B2D4-19D00960E9A0

P2860

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

http://www.wikidata.org/entity/Q28343848

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@ast

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@en

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@nl

type

label

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@ast

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@en

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@nl

prefLabel

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@ast

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@en

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@nl

P1433

Q28343848-9A580205-861D-49EA-92E8-B23DC2A32D00

P1476

Q28343848-06C7092C-41A2-4AF8-986B-ADE1C66DF85F

P2093

Q28343848-07C269E8-0C02-4B3E-AA49-F91EBA9EB56F

Q28343848-15B9B065-C7A5-49B0-9397-16E6B5B26CC5

Q28343848-27C905B1-0F62-44D9-9B95-1958A4684ED3

Q28343848-40143FA0-21EC-4488-80C3-86D44215BB2A

Q28343848-4F51B56D-0257-4811-8DFE-37445A4FD727

Q28343848-7456E08D-B5C9-4FD7-A7FF-74D48624F7E6

Q28343848-78AD52FD-4DC9-4A2F-B118-01BC73630838

Q28343848-E778B856-8E9B-4FB4-B386-513642EDD569

Q28343848-F167A481-922A-4783-9AF1-ACB5C8533B20

P2860

Q28343848-02A0FE5F-C107-408B-B635-E0D3FF5B5DBE

Q28343848-15D5F124-20B6-4015-B407-50EFFF9C4516

Q28343848-20427342-846B-4496-968B-320C10C5ED7A

Q28343848-2FB7F37B-95CD-40FE-9DE1-DA7D6C960105

Q28343848-331D9100-F4BA-4F95-A73F-8558663F30E7

Q28343848-3B7ED135-2E3D-4D66-8EA6-A1C0BA4B868C

Q28343848-53B05D90-E0C3-48AB-95AC-2D8742149037

Q28343848-53EDBC21-D3A6-46A8-A7E4-E814D4DEDB0F

Q28343848-6904B419-4E20-4DD1-91CD-41F103FA34B8

Q28343848-6DF31653-6E9C-4703-B6E4-B110EA84DBBC

P304

Q28343848-ABAD6145-8C34-4344-A42F-38DC379D8A8A

P31

Q28343848-60DA0216-9EC2-4EB5-9932-9B350B7828FF

P3181

Q28343848-66CE4BBC-16A2-43B6-BBA8-D77BFE4C5A77

P356

Q28343848-E5A8C239-686B-4794-A0F2-1745F7D2C30E

P407

Q28343848-C7A9043D-FB78-4DCB-AB1A-C5B9F597F68E

P433

Q28343848-3770A62A-42A2-4823-BD77-FFD6EE1F6FB4

P478

Q28343848-EB7C9C32-B3DD-46DE-AFFA-CED9EE2BE97A

P577

Q28343848-B8D66EA3-0958-44B3-A44B-435FD546C44E

P5875

Q28343848-BDB45BE0-5B5E-48B6-BEE9-7B033C6924CD

P698

Q28343848-E5844181-5CD8-4A7B-B871-2F1F2F21DD73

P932

Q28343848-AB77D986-15CD-41F3-BEA6-8A8AD1F09659

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Signal transducer and activato ...... rubicin-induced cardiomyopathy

@en

P2093

E Tone

http://www.w3.org/2001/XMLSchema#string

K Kunisada

http://www.w3.org/2001/XMLSchema#string

K Yamauchi-Takihara

http://www.w3.org/2001/XMLSchema#string

M Funamoto

http://www.w3.org/2001/XMLSchema#string

M Okabe

http://www.w3.org/2001/XMLSchema#string

S Negoro

http://www.w3.org/2001/XMLSchema#string

S Yamada

http://www.w3.org/2001/XMLSchema#string

T Kishimoto

http://www.w3.org/2001/XMLSchema#string

T Osugi

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy

Characterization of human cardiac myosin heavy chain genes

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

Cytokine signal transduction

Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity

Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro

STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities

P304

315-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

611438

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.97.1.315

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51363937

http://www.w3.org/2001/XMLSchema#string

P698

10618415

http://www.w3.org/2001/XMLSchema#string

P932

26660

http://www.w3.org/2001/XMLSchema#string